• Home

  • About

  • Technology

  • Clinical Applications

  • Pre-Clinical Support

  • Clinical Research

  • News & Events

  • Contact

  • More

    The Thermedical® Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.  The use of the Thermedical Ablation System for any specific soft tissue indication has not been evaluated or approved by the US FDA. In addition, use of the Thermedical Ablation System for the treatment of VT is investigational.  No device is approved for use, or for sale in any market.

    The Thermedical® Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.  Use of the Thermedical Ablation System for any specific soft tissue indication has not been evaluated or approved by the US FDA.

    Use of the Thermedical Ablation System for the treatment of VT is investigational and is not approved for use or sale in any market.

    150 Bear Hill Road,  Waltham, MA 02451-1036
    781.373.3688

    ©Copyright Thermedical, Inc. 2011-2015. All Rights Reserved. | Copyright and Trademark Notice 
    Thermedical® and Durablate™ are trademarks of Thermedical, Inc. registered in the United States and Internationally.

    Clinical

    Research

    Thermedical has two studies recruiting patients in the United States and Canada designed to treat patients who have recurrent monomorphic VT and have failed drug therapy and prior ablation.  Contact the participating institution if you have interest in participating in the study.

    • Publications

    Clinical Trials.gov Links:

    • US Study

    • Canadian Study